Monogram Orthopaedics (MGRM) Competitors $2.97 -0.08 (-2.59%) Closing price 03:58 PM EasternExtended Trading$2.86 -0.12 (-3.90%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRM vs. NPCE, CLPT, TCMD, SMLR, NNOX, STIM, SMTI, ZIMV, RCEL, and SNWVShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include NeuroPace (NPCE), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Semler Scientific (SMLR), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. NeuroPace ClearPoint Neuro Tactile Systems Technology Semler Scientific Nano-X Imaging Neuronetics Sanara MedTech ZimVie AVITA Medical SANUWAVE Health NeuroPace (NASDAQ:NPCE) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk. Does the MarketBeat Community prefer NPCE or MGRM? NeuroPace received 28 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 75.00% of users gave Monogram Orthopaedics an outperform vote while only 60.78% of users gave NeuroPace an outperform vote. CompanyUnderperformOutperformNeuroPaceOutperform Votes3160.78% Underperform Votes2039.22% Monogram OrthopaedicsOutperform Votes375.00% Underperform Votes125.00% Is NPCE or MGRM more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to NeuroPace's net margin of -36.74%. Monogram Orthopaedics' return on equity of -130.90% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets NeuroPace-36.74% -205.41% -28.29% Monogram Orthopaedics N/A -130.90%-106.38% Which has better earnings and valuation, NPCE or MGRM? Monogram Orthopaedics has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Monogram Orthopaedics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroPace$79.91M4.79-$32.96M-$0.95-12.31Monogram Orthopaedics$365.00K294.88-$13.74M-$0.46-6.63 Which has more volatility and risk, NPCE or MGRM? NeuroPace has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Do insiders and institutionals have more ownership in NPCE or MGRM? 78.8% of NeuroPace shares are held by institutional investors. Comparatively, 0.4% of Monogram Orthopaedics shares are held by institutional investors. 22.2% of NeuroPace shares are held by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor NPCE or MGRM? In the previous week, NeuroPace had 3 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 4 mentions for NeuroPace and 1 mentions for Monogram Orthopaedics. NeuroPace's average media sentiment score of 1.59 beat Monogram Orthopaedics' score of 0.62 indicating that NeuroPace is being referred to more favorably in the media. Company Overall Sentiment NeuroPace Very Positive Monogram Orthopaedics Positive Do analysts prefer NPCE or MGRM? NeuroPace presently has a consensus price target of $15.20, suggesting a potential upside of 30.03%. Monogram Orthopaedics has a consensus price target of $5.40, suggesting a potential upside of 77.05%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, analysts plainly believe Monogram Orthopaedics is more favorable than NeuroPace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroPace 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryMonogram Orthopaedics beats NeuroPace on 11 of the 19 factors compared between the two stocks. Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$107.63M$4.39B$5.56B$7.83BDividend YieldN/A39.94%5.11%4.22%P/E Ratio-6.4930.6722.4418.48Price / Sales294.8854.91393.95103.59Price / CashN/A51.0838.1834.62Price / Book7.096.116.774.25Net Income-$13.74M$68.15M$3.22B$248.23M7 Day Performance6.64%-0.12%1.45%0.89%1 Month Performance3.74%-2.24%3.96%3.53%1 Year Performance56.41%24.15%16.07%5.08% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics2.4578 of 5 stars$2.97-2.6%$5.40+81.8%+47.7%$104.84M$364,999.00-6.3228NPCENeuroPace3.872 of 5 stars$10.54-2.3%$15.20+44.2%-10.0%$343.18M$79.91M-10.54170Upcoming EarningsShort Interest ↓Positive NewsCLPTClearPoint Neuro2.1032 of 5 stars$11.95-2.4%$25.00+109.2%+165.0%$334.36M$31.39M-17.32110TCMDTactile Systems Technology2.9504 of 5 stars$13.45+0.9%$18.00+33.8%+2.5%$318.31M$292.98M19.21980Upcoming EarningsSMLRSemler Scientific3.1054 of 5 stars$29.83-8.2%$71.00+138.0%+26.6%$286.28M$56.29M6.08120Upcoming EarningsGap UpNNOXNano-X Imaging2.5797 of 5 stars$4.75-8.7%$12.00+152.6%-43.9%$274.45M$11.28M-5.59190Positive NewsSTIMNeuronetics1.9817 of 5 stars$3.88+3.2%$5.50+41.8%+30.0%$255.36M$74.89M-3.15180Upcoming EarningsNews CoverageSMTISanara MedTech2.0274 of 5 stars$28.66-2.6%$48.50+69.2%+0.3%$255.13M$86.67M-28.9560News CoveragePositive NewsZIMVZimVie2.6694 of 5 stars$8.92-5.0%$19.50+118.6%-40.4%$248.40M$449.75M-0.682,700Positive NewsRCELAVITA Medical1.6955 of 5 stars$9.10-1.2%$17.25+89.6%+15.4%$240.56M$64.25M-3.81130Upcoming EarningsPositive NewsSNWVSANUWAVE HealthN/A$28.00-6.6%N/AN/A$239.37M$32.63M-7.1840 Related Companies and Tools Related Companies NeuroPace Competitors ClearPoint Neuro Competitors Tactile Systems Technology Competitors Semler Scientific Competitors Nano-X Imaging Competitors Neuronetics Competitors Sanara MedTech Competitors ZimVie Competitors AVITA Medical Competitors SANUWAVE Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRM) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.